A Five-year Surveillance of Carbapenemase-producing Klebsiella pneumoniae in a Pediatric Hospital in China Reveals Increased Predominance of NDM-1

Biomedical and Environmental Sciences

Volumn 30, Issue 8, 2017, Pages 562-569

  DONG, Fang ^a   LU, Jie ^a   WANG, Yan ^a   SHI, Jin ^a   ZHEN, Jing Hui ^a   CHU, Ping ^a   ZHEN, Yang ^a   HAN, Shu Jing ^a   GUO, Yong Li ^a   SONG, Wen Qi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Carbapenemases; Klebsiella pneumoniae; Microbial drug resistance

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE NDM-1; CARBAPENEMASE;

CHILD; CHINA; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEALTH SURVEY; HOSPITAL; HUMAN; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; TIME FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CHILD; CHINA; DRUG RESISTANCE; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOSPITALS, PEDIATRIC; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; TIME FACTORS;

EID: 85028346223     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/bes2017.075     Document Type: Article

References (29)

1. Struve, C, Krogfelt, K, Pathogenic potential of environmental Klebsiella pneumoniae isolates. Environ Microbiol 6 (2004), 584–590.
2. Tzouvelekis, LS, Markogiannakis, A, Psichogiou, M, et al. Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions. Clin Microbiol Rev 25 (2012), 682–707.
3. Holt, KE, Wertheim, H, Zadoks, RN, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. P Natl Acad Sci USA 112 (2015), E3574–E3581.
4. van Duin, D, Kaye, KS, Neuner, EA, et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 75 (2013), 115–120.
5. Correa, L, Martino, M, Marra, A, et al. 2013. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis, 13, 2013, 80.
6. Centers for Disease Control and Prevention (CDC), Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 62 (2013), 165–170.
7. Deshpande, LM, Jones, RN, Fritsche, TR, et al. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004). Microb Drug Resist 12 (2006), 223–230.
8. Chen, L, Mathema, B, Chavda, KD, et al. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 22 (2014), 686–696.
9. Pitout, JDD, Nordmann, P, Poirel, L, Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob Agents Chemother 59 (2015), 5873–5884.
10. Nordmann, P, Naas, T, Poirel, L, Global Spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17 (2011), 1791–1798.
11. Dai, YY, Zhang, CF, Ma, XL, et al. Outbreak of carbapenemase-producing Klebsiella pneumoniae neurosurgical site infections associated with a contaminated shaving razor used for preoperative scalp shaving. Am J Infect Control 42 (2014), 805–806.
12. Liu, Y, Wan, LG, Deng, Q, et al. First description of NDM-1-, KPC-2-, VIM-2-and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital. Epidemiol Infect 143 (2015), 376–384.
13. Zhou, J, Li, GP, Ma, XJ, et al. Outbreak of colonization by carbapenemase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Investigation, control measures and assessment. Am J Infect Control 43 (2015), 1122–1124.
14. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement M100-S24, 2014, CLSI, Wayne. Pennsylvania.
15. Deshpande, LM, Rhomberg, PR, Sader, HS, et al. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999–2005). Diagn Microbiol Infect Dis 56 (2006), 367–372.
16. NeilWoodford, Rapid characterization of beta-lactamases by multiplex PCR. Methods Mol Biol 642 (2010), 181–192.
17. Shanthi, M, Sekar, U, Arunagiri, K, et al. OXA-181 Beta Lactamase is not a Major Mediator of Carbapenem Resistance in Enterobacteriaceae. J Clin Diagn Res 7 (2013), 1986–1988.
18. Ahmed-Bentley, J, Chandran, AU, Joffe, AM, et al. Gram-Negative Bacteria That Produce Carbapenemases Causing Death Attributed to Recent Foreign Hospitalization. Antimicrob Agents Chemother 57 (2013), 3085–3091.
19. Hu, FP, Guo, Y, Zhu, DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol Infect 22 (2016), S9–S14.
20. Hu, FP, Zhu, DM, Wang, F, et al. CHINET surveillance of distribution and susceptibility of carbapenem-resistant Enterobacteriaceae isolates in 2012. Chinese Journal of Infection and Chemotherapy 14 (2014), 382–386 (In Chinese).
21. Meng, JH, Zhu, L, Li, WL, et al. Antimicrobial resistance surveillance of gram-negative bacteria from children in China, 2012. Chin J Clin Pharmacol 31 (2015), 990–992 (In Chinese).
22. Jin, Y, Shao, CH, Li, J, et al. Outbreak of Multidrug Resistant NDM-1-Producing Klebsiella pneumoniae from a Neonatal Unit in Shandong Province, China. PLoS One, 10, 2015, e0119571.
23. Centers for Disease Control and Prevention (CDC), Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase – United States, 2010. MMWR Morb Mortal Wkly Rep, 59, 2010, 750.
24. Sa'nchez-Romero, I, Asensio, A, Oteo, J, et al. Nosocomial Outbreak of VIM-1-Producing Klebsiella pneumoniae Isolates of Multilocus Sequence Type 15: Molecular Basis, Clinical Risk Factors, and Outcome. Antimicrob Agents Chemother 56 (2012), 420–427.
25. Chen, LR, Zhou, HW, Cai, JC, et al. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate. Diagn Microbiol Infect Dis 65 (2009), 163–167.
26. Dong, F, Song, WQ, Xu, XW, et al. Analysis of carbapenemase genotypes in carbapenem-nonsusceptible Enterobacteriaceae strains isolated from pediatric patient. Chinese Journal of Infection and Chemotherapy 13 (2013), 270–274 (In Chinese).
27. Bax, BD, Chan, PF, Eggleston, DS, et al. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature 466 (2010), 935–940.
28. Nordmann, Couard, JP, Sansot, D, et al. Emergence of an Autochthonous and Community-Acquired NDM-1-Producing Klebsiella pneumoniae in Europe. Clin Infect Dis 54 (2012), 150–151.
29. Yong, D, Toleman, MA, Giske, CG, et al. Characterization of a New Metallo-beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrob Agents Chemother 53 (2009), 5046–5054.